- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00627770
Lower Leg Edema Evaluation After Total Knee Arthroplasty Using Bioimpedance
January 28, 2009 updated by: Haute Ecole de Santé Vaud
Validation of a Procedure Using Bioimpedance to Measure the Edema of Lower Leg of Patients After Total Knee Surgery
The purpose of this study is to evaluate the applicability and measurement properties of bioimpedance spectroscopy for postsurgical edema assessment after total knee arthroplasty
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Current measurement techniques of edema are not adapted or not convenient for assessment in the post surgical environment.
Developement of a convenient, quick and reliable method could be useful to facilitate edema evaluation in this context.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lausanne, Switzerland, 1005
- Département de l'Appareil Locomoteur - CHUV
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- knee replacement surgery
Exclusion Criteria:
- pacemaker
- cardiac defibrillator
- other metallic implant than knee arthroplasty
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
bioimpedance ratio right/left
Time Frame: presurgery, 2 and 8 days post surgery
|
presurgery, 2 and 8 days post surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Claude A Pichonnaz, physiother., Haute Ecole de Santé Vaud
- Study Director: Brigitte M Jolles, PhD MER MSc, Département de l'Appareil Locomoteur - CHUV + Faculté des sciences et techniques de l'ingénieur (STI) - EPFL
- Principal Investigator: Correvon Marc, Engineer, Haute Ecole Vaudoise d'Ingénierie et de Gestion
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ACTUAL)
November 1, 2008
Study Completion (ACTUAL)
November 1, 2008
Study Registration Dates
First Submitted
February 6, 2008
First Submitted That Met QC Criteria
February 22, 2008
First Posted (ESTIMATE)
March 3, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
January 29, 2009
Last Update Submitted That Met QC Criteria
January 28, 2009
Last Verified
January 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HECVSante01
- SAGE-X 19860
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
Hoffmann-La RocheCompletedDiabetic Macular Edema | Uveitic Macular EdemaUnited States
-
Alexandria UniversityRecruitingDiabetic Macular Edema | Center-involved Diabetic Macular EdemaEgypt
-
Curacle Co., Ltd.Not yet recruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DME
-
OcugenRecruitingDiabetic Macular Edema | Center Involved Diabetic Macular EdemaUnited States
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
Eye-yon MedicalCompletedChronic Cornel EdemaNetherlands, Israel, Germany, Spain
-
EyePoint Pharmaceuticals, Inc.RecruitingDiabetic Macular Edema | Diabetic Macular Edema (DME) | DMEIsrael, United States, Poland, Germany, Slovakia
Clinical Trials on bioimpedance spectroscopy ImpediMed SFB7 Brisbane Australia
-
RWTH Aachen UniversityPhilips Technology Aachen GermanyUnknownAcute Decompensated Heart Failure (ADHF) | Acute Cardiogenic Pulmonary Edema (ACPE)Germany